NewsEdge Corporation Extends Global Enterprise Agreement with AstraZeneca

Strategic Insights -

NewsEdge Corporation, a leading provider of business-oriented eContent syndication, has extended its global enterprise agreement with AstraZeneca, a top-five pharmaceutical company, to provide industry news and company information to users worldwide. AstraZeneca will integrate NewsEdge Review Topics into its intranet to enable all employees to track industry developments, clinical areas, and competitor information. The company will also use NewsEdge Review Topics in various external Web sites to provide targeted information to different Web communities interested in specific areas, such as Alzheimer's disease.

Key Takeaways:

  • NewsEdge Corporation has extended its global enterprise agreement with AstraZeneca to provide industry news and company information to users worldwide.
  • AstraZeneca will integrate NewsEdge Review Topics into its intranet to enable all employees to track industry developments, clinical areas, and competitor information.
  • The company will also use NewsEdge Review Topics in various external Web sites to provide targeted information to different Web communities interested in specific areas, such as Alzheimer's disease.
  • AstraZeneca's Commercial Intelligence Group will provide the solution, utilizing NewsEdge Refinery technology to deliver highly targeted eContent on more than 1,500 business topics from more than 2,000 sources.
  • NewsEdge Review Topics manage information from hundreds of leading global media providers, putting them into a set of finely tuned topics that make content usable.
  • NewsEdge has a dedicated team of news reviewers who provide the final quality assurance and relevancy ranking, ensuring that users see the most important news at first glance.
  • The agreement is a prime example of a company adopting progressive solutions to maintain an overall competitive edge in their field.
  • AstraZeneca is a major international healthcare business with healthcare sales of over $15 billion and leading positions in sales of gastrointestinal, oncology, and other product areas.
  • NewsEdge serves more than 1,700 sites and companies with highly targeted eContent solutions.

Statistics:

  • AstraZeneca has healthcare sales of over $15 billion.
  • NewsEdge serves more than 1,700 sites and companies with highly targeted eContent solutions.
  • NewsEdge Refinery technology delivers highly targeted eContent on more than 1,500 business topics from more than 2,000 sources.
  • NewsEdge has a dedicated team of news reviewers who provide quality assurance and relevancy ranking.

Sources:

  • Business Wire, October 16, 2000
  • NewsEdge Corporation website, http://www.newsedge.com
  • AstraZeneca website
  • NASDAQ: NEWZ
  • SEC reports filed by NewsEdge Corporation